Beta-Thalassemia Recruiting Phase Trials for Deferasirox (DB01609)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02474420Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia PatientsTreatment